Nextgen Biotech

Call us:

Zynesp 200mcg - Darbepoetin Alfa Injection

Zynesp 200mcg Injection contains Darbepoetin Alfa, an erythropoiesis-stimulating agent (ESA) that helps increase red blood cell production. It is primarily used to treat anemia caused by chronic kidney disease (CKD) and chemotherapy in cancer patients.

Choose Quantity:

-
+
Share
General Information:
Generic Name: Darbepoetin Alfa
Brand Name: Zynesp
Packing: Pre-filled syringe
Strength: 200 mcg
Manufacturer: Zydus Cadila
Form: Injectable solution
Category: Hematopoietic Growth Factors / Erythropoiesis-Stimulating Agents (ESA)
Product Introduction:
Zynesp 200mcg Injection is a prescription medication used to manage anemia in patients with chronic kidney disease (CKD) and those undergoing chemotherapy. By stimulating the bone marrow to produce more red blood cells, it helps to reduce the need for blood transfusions. This injection is administered subcutaneously (under the skin) or intravenously (into a vein).

Uses of Zynesp 200mcg Injection:
Zynesp 200mcg Injection is used for:
  1. Anemia due to Chronic Kidney Disease (CKD) – Helps improve red blood cell production in CKD patients.
  2. Chemotherapy-Induced Anemia – Treats anemia in cancer patients receiving chemotherapy.
  3. Anemia in HIV Patients on Zidovudine Therapy – Used in specific cases to correct anemia.
  4. Preoperative Use in Certain Surgeries – Reduces the need for blood transfusions before surgery.
  5. Anemia in Bone Marrow Disorders (e.g., Myelodysplastic Syndrome) – Stimulates blood cell production in certain hematologic conditions.
  6. Anemia Associated with Chronic Diseases – May be used in select cases where anemia is a result of chronic illness.

Storage Instructions:
  1. Store at a temperature between 2°C to 8°C in the refrigerator.
  2. Do not freeze or shake the pre-filled syringe.
  3. Keep away from direct sunlight and heat exposure.
  4. Keep out of reach of children.

How Zynesp 200mcg Works (Mechanism of Action):
Darbepoetin Alfa is a synthetic erythropoiesis-stimulating agent (ESA) that mimics the function of natural erythropoietin. It works by binding to erythropoietin receptors on bone marrow cells, stimulating the production of red blood cells (erythropoiesis). This helps in maintaining adequate hemoglobin levels, reducing anemia-related symptoms, and decreasing the need for blood transfusions.

Side Effects:
Common Side Effects:
  1. High blood pressure (hypertension)
  2. Swelling in legs and feet
  3. Headache
  4. Nausea and vomiting
  5. Fatigue and dizziness
  6. Joint or muscle pain
Severe Side Effects (Rare but Serious):
  1. Increased risk of blood clots (deep vein thrombosis, stroke, heart attack)
  2. Seizures
  3. Heart failure or cardiac arrest
  4. Pure red cell aplasia (PRCA) – A rare condition where the body stops producing red blood cells
  5. Severe allergic reactions (rash, breathing difficulty, facial swelling)
Seek immediate medical attention if you experience severe side effects.

Dosage (Typical Recommended Dose):
For Chronic Kidney Disease (CKD):
  1. Initial dose: 0.45 mcg/kg once per week OR 0.75 mcg/kg once every two weeks via subcutaneous (SC) or intravenous (IV) injection.
  2. The dose is adjusted based on hemoglobin levels and patient response.
For Chemotherapy-Induced Anemia:
  1. 500 mcg subcutaneously once every three weeks.
  2. The dosage may be modified based on the patient’s hemoglobin levels.
Important: Dosage adjustments should always be made under medical supervision.

Method of Administration:
  1. Can be administered subcutaneously (under the skin) or intravenously (into a vein).
  2. Rotate injection sites to prevent irritation or swelling.
  3. Do not shake the syringe before use.
  4. Do not inject into red, swollen, or bruised areas.
  5. Dispose of used syringes in a sharps disposal container.

Precautions:
  1. Monitor hemoglobin levels regularly to avoid the risk of cardiovascular complications.
  2. Do not use if you have uncontrolled high blood pressure.
  3. Patients with a history of blood clots or stroke should use this medication with caution.
  4. Not recommended for patients with pure red cell aplasia (PRCA).
  5. Use cautiously in pregnant and breastfeeding women.
  6. Iron supplementation may be required for optimal response to therapy.

Drug Interactions:
Zynesp 200mcg Injection may interact with:
  1. Blood pressure medications (antihypertensives) – Can cause changes in blood pressure levels.
  2. Blood thinners (anticoagulants) (e.g., warfarin, heparin) – May increase the risk of clotting.
  3. Iron supplements – Necessary for better effectiveness but should be monitored.
  4. Certain chemotherapy drugs – May require dosage modifications.
Always inform your doctor about all medications you are taking before starting treatment.

Allergies (Warnings for Allergic Reactions):
  1. Avoid using Zynesp 200mcg if you are allergic to Darbepoetin Alfa or any excipients in the injection.
  2. Symptoms of an allergic reaction include rash, swelling, difficulty breathing, and dizziness.
  3. Seek emergency medical help if you experience any allergic symptoms.

Overdose Information:
Symptoms of overdose:
  1. Severe high blood pressure
  2. Increased risk of blood clots, stroke, or heart attack
  3. Excessively high hemoglobin levels
What to do in case of overdose?
  1. Seek immediate medical attention.
  2. The doctor may adjust or discontinue the medication and provide supportive treatment.

Missed Dose Instructions:
  1. If you miss a dose, take it as soon as you remember.
  2. If it is close to the next scheduled dose, skip the missed dose and continue the regular schedule.
  3. Do not take extra doses to make up for the missed one.

Additional Notes:
  1. Regular blood tests are essential to monitor hemoglobin levels and adjust dosage accordingly.
  2. The lowest effective dose should be used to reduce the risk of cardiovascular complications.
  3. Patients should maintain adequate iron levels for better medication response.
  4. Do not use expired or damaged syringes.

In The Same Category

Cart